Access cutting-edge esophageal cancer treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.
Access esophageal cancer specialists in Fullerton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related esophageal cancer treatment provided free
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd) in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) who have experienced disease progression following treatment with a platinum-based systemic therapy and an immune checkpoint inhibitor (ICI) compared with investigator's choice of chemotherapy (ICC).
Sponsor: Daiichi Sankyo
Check if you qualify for this esophageal cancer clinical trial in Fullerton, CA
If you're searching for esophageal cancer treatment options in Fullerton, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.